Hepatitis C In Drug And Alcohol Settings

AWST: 3:30 pm – 6:30 pm

This free online training aims to provide participants with the knowledge and confidence to increase the management of HCV in alcohol and other drug settings.

PeOple who inject drugs represent approximately 90% of newly acquired hepatitis C (HCV) infections. This course aims to provide addiction physicians, general practitioners, nurse practitioners, and other practitioners working in Drug and Alcohol settings with the skills and knowledge to diagnose HCV, manage comorbidities and treat HCV.

This online course will be delivered in three parts:

1. is a 1.5-hour eLearning component introducing the learner to assessment, management and treatment of hepatitis C in drug and alcohol settings.
2. is a 3-hour facilitated online training sessions building on the knowledge and skills gained in Part 1 through practical case discussions.
3. is a tailored capacity strengthening toolkit including: a checklist for the assessment and treatment of HCV in drug and alcohol settings; local referral pathways; Fibroscan® access forms; assessment pro forma; and quick reference guides.

Learning Objectives:

• Describe risk factors for HCV, enabling discussions with clients around prevention and harm reduction
• Screen, order and interpret tests appropriately to diagnose chronic HCV infection
• Describe the recommended pre-treatment assessment, including liver disease staging
• Determine the appropriate antiviral therapy for treatment of HCV and explain treatment to patient
• Implement monitoring and post-treatment follow-up recommendations

Target Audience:

Addiction medicine physicians, general practitioners, nurse practitioners, and other practitioners prescribing or intending to prescribe s85 DAA medication in alcohol and other drug settings (open also to those working in primary care settings). Open to attendees Australia wide.

Accreditation:

This education is a CPD Accredited Activity under the RACGP CPD Program. 40 points allocated.

REGISTER HERE